RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and ChinaFuture growth in the biopharma industry will increasingly focus on bio-platforms.
Investing in a bio-platform, understanding the technology behind it, and mastering the repeatable operations enables efficiencies, speed, and lower costs, yielding a competitive advantage over firms following a traditional asset strategy.
ONCY's pelareorep is an immune molecule platform technology that can be used to treat multiple cancers across multiple therapeutic areas (TAs).